MOTS
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2024 Q1 | -0.88 | $64,000 | -$2M |
| 2023 Q4 | -1.81 | $64,000 | -$2M |
| 2023 Q3 | -4.28 | $86,000 | -$2M |
| 2023 Q2 | -5.95 | $113,000 | -$3M |
| 2023 Q1 | -13.81 | $56,000 | -$5M |
| 2022 Q4 | -12.65 | $109,000 | -$4M |
| 2022 Q3 | -26.67 | $278,000 | -$4M |
| 2022 Q2 | -30.92 | $185,000 | -$5M |